Alzheimer's proteins in ICU survivors

While modern medicine has increased the number of people who survive a stay in the Intensive Care Unit (ICU), survivors have a high risk of developing problems with thinking and memory, a phenomenon called cognitive impairment.

Cognitive impairment is also one of the hallmarks of Alzheimer's disease.

James Jackson, PsyD, and colleagues used PET imaging in 14 ICU survivors to look for a malfunctioning protein common in the brains of patients with Alzheimer's disease—beta-amyloid.

The researchers were the first to image beta-amyloid in this patient population. They also followed the patients with comprehensive cognitive testing for six years after their hospital stay.

The investigators reported in the Journal of Critical Care that only two of the patients had measurable beta-amyloid in their brains, suggesting that beta-amyloid may not be the mechanism that underlies dementia in ICU survivors.

The study paves the way for future studies to uncover the mechanisms of among survivors of critical illnesses.


Explore further

Can poor sleep boost odds for Alzheimer's?

More information: James C. Jackson et al. Florbetapir-PET β-amyloid imaging and associated neuropsychological trajectories in survivors of critical illness: A case series, Journal of Critical Care (2017). DOI: 10.1016/j.jcrc.2017.10.016
Provided by Vanderbilt University
Citation: Alzheimer's proteins in ICU survivors (2018, March 29) retrieved 24 March 2019 from https://medicalxpress.com/news/2018-03-alzheimer-proteins-icu-survivors.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
7 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more